U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07289321) titled 'Addition of Tramadol or Magnesium to Ropivacaine Solution in UG-bilateral TAP Block and Investigation of Their Effect on Patients Under Robotic Radical Prostatectomy.' on Dec. 04.

Brief Summary: Prostate cancer is the second most common cause of death in men, making radical prostatectomy a relatively common procedure. Among other pharmaceutical substances, tramadol and magnesium are well-known drugs that have been researched in recent decades for their different roles in pain control. Since both appear to enhance the action of local anesthetics, this clinical study will compare and re-evaluate their effect on the duration and qualit...